Related Experiment Video
Updated: Aug 5, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
Hypomethylation of GNA15 Promotes Pancreatic Ductal Adenocarcinoma Progression and Macrophage M2 Polarization via
Weihui Guo1, Zhenyuan Qian1, Lei Wang1
1Department of General Surgery, Cancer Center, Division of Gastrointestinal and Pancreatic Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Abstract:
The complexity of pancreatic ductal adenocarcinoma (PDAC) progression, coupled with the lack of effective immunotherapy, underscores the imperative to deepen our understanding of its mechanisms and identify suitable immune-targeted interventions. The G protein alpha subunit 15 (GNA15) is significantly upregulated in PDAC and correlates with poor prognosis in patients with PDAC. Mechanistically, our study demonstrates that TET3 upregulates GNA15 expression through demethylation in PCs, and the highly expressed GNA15 activates the phosphorylation of STAT3 via the GP130-JAK signaling pathway, thereby promoting the expression and release of CXCL8. Subsequently, CXCL8 released by PCs binds to CXCR1 or CXCR2 in macrophages to promote M2 polarization. Additionally, high GNA15 expression was associated with Gemcitabine resistance, and the combination of Reparixin and Gemcitabine has shown favorable antitumor efficacy in PDAC. Collectively, we elucidated that GNA15 drives PDAC progression and M2 macrophage polarization via the STAT3-CXCL8 axis and established targeting GNA15-STAT3-CXCL8 as a novel strategy to improve PDAC therapies.
Insights
Pancreatic cancer (PDAC) progression involves GNA15, which promotes M2 macrophage polarization via the STAT3-CXCL8 pathway. Targeting this axis offers a new strategy for PDAC treatment.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Pancreatic ductal adenocarcinoma (PDAC) presents complex progression challenges and limited immunotherapy options.
- G protein alpha subunit 15 (GNA15) upregulation in PDAC correlates with poor patient prognosis.
Purpose of the Study:
- To elucidate the role of GNA15 in PDAC progression and immune modulation.
- To identify GNA15 as a potential therapeutic target for PDAC.
Main Methods:
- Investigated TET3-mediated GNA15 regulation via demethylation in pancreatic cancer cells (PCs).
- Analyzed GNA15-induced STAT3 phosphorylation and CXCL8 expression through the GP130-JAK pathway.
- Examined CXCL8's role in macrophage M2 polarization via CXCR1/CXCR2.
- Assessed GNA15 expression's association with Gemcitabine resistance and combination therapy efficacy.
Main Results:
- TET3 upregulates GNA15 expression in PCs via demethylation.
- GNA15 activates STAT3 phosphorylation, promoting CXCL8 release.
- CXCL8 drives M2 polarization in macrophages.
- High GNA15 expression is linked to Gemcitabine resistance.
- Combination of Reparixin and Gemcitabine showed antitumor efficacy.
Conclusions:
- GNA15 drives PDAC progression and M2 macrophage polarization through the STAT3-CXCL8 axis.
- Targeting the GNA15-STAT3-CXCL8 pathway represents a novel therapeutic strategy for PDAC.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
